T. Rowe Price Associates’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,848
| Closed | -$33K | – | 3076 |
|
|
2025
Q1 | $33K | Hold |
35,848
| – | – | ﹤0.01% | 2971 |
|
|
2024
Q4 | $57K | Buy |
35,848
+8,008
| +29% | +$12.7K | ﹤0.01% | 2908 |
|
|
2024
Q3 | $55K | Buy |
27,840
+3,888
| +16% | +$7.68K | ﹤0.01% | 2914 |
|
|
2024
Q2 | $40K | Buy |
23,952
+572
| +2% | +$955 | ﹤0.01% | 2876 |
|
|
2024
Q1 | $121K | Buy |
23,380
+2,545
| +12% | +$13.2K | ﹤0.01% | 2744 |
|
|
2023
Q4 | $120K | Buy |
20,835
+4,637
| +29% | +$26.7K | ﹤0.01% | 2684 |
|
|
2023
Q3 | $78K | Buy |
16,198
+5,652
| +54% | +$27.2K | ﹤0.01% | 2702 |
|
|
2023
Q2 | $45K | Hold |
10,546
| – | – | ﹤0.01% | 2808 |
|
|
2023
Q1 | $56K | Buy |
+10,546
| New | +$56K | ﹤0.01% | 2774 |
|